Getting smart with coagulation

被引：5

作者：

Favaloro, Emmanuel J. ^{[1
,2
,3
]}

Pasalic, Leonardo ^{[1
,2
,4
]}

Lippi, Giuseppe ^{[5
]}

机构：

[1] Westmead Hosp, NSW Hlth Pathol, Inst Clin Pathol & Med Res ICPMR, Dept Haematol, Westmead, NSW, Australia

[2] Sydney Ctr Thrombosis & Haemostasis, Westmead, NSW, Australia

[3] Charles Sturt Univ, Fac Sci & Hlth, Wagga Wagga, NSW, Australia

[4] Univ Sydney, Westmead, NSW, Australia

[5] Univ Verona, Sect Clin Biochem, Verona, Italy

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2022年 / 20卷 / 07期

关键词：

ANTICOAGULATION THERAPY; FACTOR-II; MANAGEMENT; SMARTPHONES; LEVEL;

D O I：

10.1111/jth.15691

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1519 / 1522

页数：4

共 23 条

[1] Therapeutic monitoring of unfractionated heparin - trials and tribulations [J].

Baluwala, Israfil ;

Favaloro, Emmanuel J. ;

Pasalic, Leonardo .

EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (07) :595-605

[2] Micro-mechanical blood clot testing using smartphones [J].

Chan, Justin ;

Michaelsen, Kelly ;

Estergreen, Joanne K. ;

Sabath, Daniel E. ;

Gollakota, Shyamnath .

NATURE COMMUNICATIONS, 2022, 13 (01)

[3] Warfarin Monitoring in Antiphospholipid Syndrome and Lupus Anticoagulant [J].

Crowl, Ashley ;

Schullo-Feulner, Anne ;

Moon, Jean Y. .

ANNALS OF PHARMACOTHERAPY, 2014, 48 (11) :1479-1483

[4] Single-center determination of reference factor II and factor X activity level values for the monitoring of vitamin K antagonist therapy [J].

Desage, Stephanie ;

Jousselme, Emilie ;

Negrier, Claude ;

Nougier, Christophe ;

Le Quellec, Sandra ;

Jourdy, Yohann .

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 (05) :E121-E123

[5] Thrombin generation and factor X assays for the assessment of warfarin anticoagulation in thrombotic antiphospholipid syndrome [J].

Efthymiou, Maria ;

Lawrie, Andrew S. ;

Mackie, Ian ;

Arachchillage, Deepa ;

Lane, Philip J. ;

Machin, Samuel ;

Cohen, Hannah .

THROMBOSIS RESEARCH, 2015, 135 (06) :1191-1197

[6]

Favaloro EJ., 2018, ANN BLOOD, V3, P48, DOI DOI 10.21037/AOB.2018.12.02

[7] How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors [J].

Favaloro, Emmanuel J. ;

Kershaw, Geoffrey ;

Mohammed, Soma ;

Lippi, Giuseppe .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2019, 45 (01) :22-35

[8] How to Generate a More Accurate Laboratory-Based International Normalized Ratio: Solutions to Obtaining or Verifying the Mean Normal Prothrombin Time and International Sensitivity Index [J].

Favaloro, Emmanuel J. .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2019, 45 (01) :10-21

[9] Replacing warfarin therapy with the newer direct oral anticoagulants, or simply a growth in anticoagulation therapy? Implications for pathology testing [J].

Favaloro, Emmanuel J. ;

Pasalic, Leonardo ;

Lippi, Giuseppe .

PATHOLOGY, 2017, 49 (06) :639-643

[10]

Franchini, 2019, ANN BLOOD, V4, P5, DOI [10.21037/aob.2019.02.01, DOI 10.21037/AOB.2019.02.01]

← 1 2 3 →